Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04419480 · ClinicalTrials.gov registry record · NA
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
A NA study of Heart Failure and Cardiogenic Shock, sponsored by Inova Health Care Services.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04419480: Recruiting NA study of Heart Failure and Cardiogenic Shock, sponsored by Inova Health Care Services.
NCT04419480 is a NA study of Heart Failure and Cardiogenic Shock that is actively recruiting participants, run by Inova Health Care Services. The registered enrollment target is 40 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04419480, a NA study of Heart Failure and Cardiogenic Shock, is actively recruiting participants, sponsored by Inova Health Care Services.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Pilot Prospective Randomized Unblinded Pragmatic Trial of Pulmonary Artery Hemodynamic Monitoring Following Hospitalization for Cardiogenic Shock
Primary Outcome
Hierarchical endpoint at 6-months, including death (or mortality-equivalent including left ventricular assist device implantation or heart transplantation), recurrent cardiovascular hospitalization, health related quality of life change from baseline, measured by the Minnesota Living with Heart Failure Questionnaire (MLHFQ) as a continuous score, and change in log-transformed NT-proBNP level from enrollment to 6 months, evaluated by the win ratio according to the Finkelstein-Schoenfeld method
Conditions Studied
Interventions
- DEVICE CardioMEMS implantation with routine ambulatory pulmonary artery pressure monitoring and medication optimization
Study Locations (1)
Virginia
- Inova Fairfax Medical Campus - Falls Church
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-12-31 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT04419480 shows while recruiting
NCT04419480 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which CardioMEMS implantation with routine ambulatory pulmonary artery pressure monitoring and medication optimization is the first listed.
NCT04419480 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT04419480 about?
NCT04419480 is a clinical study titled "Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial". Pilot Prospective Randomized Unblinded Pragmatic Trial of Pulmonary Artery Hemodynamic Monitoring Following Hospitalization for Cardiogenic Shock
What is the current status of trial NCT04419480?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2020-12-31. Estimated completion is 2028-12-31.
What conditions does trial NCT04419480 study?
This clinical trial studies the following conditions: Heart Failure, Cardiogenic Shock, Ambulatory Hemodynamic Monitoring.
What interventions are being tested in trial NCT04419480?
The interventions under investigation include: CardioMEMS implantation with routine ambulatory pulmonary artery pressure monitoring and medication optimization (DEVICE).
Who is sponsoring clinical trial NCT04419480?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04419480 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04419480's enrollment target sits among peer trials
40 306th of 397 higher than 89 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
-
Mind Your Heart-II
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI